How do systemic anticholinergic drugs affect blood pressure, and what monitoring or precautions are recommended for patients with hypertension, cardiovascular disease, or the elderly?

Anticholinergics and Blood Pressure

Systemic anticholinergic drugs can cause tachycardia and may precipitate hypertension through their cardiovascular effects, particularly in elderly patients who are already at high risk for adverse outcomes. 1, 2, 3

Cardiovascular Effects of Anticholinergics

Anticholinergic medications block muscarinic receptors throughout the body, producing predictable cardiovascular effects:

• Tachycardia is a primary concern due to blockade of vagal tone on the heart 3
• Increased heart rate may worsen angina in patients with coronary artery disease 3
• The classic mnemonic describes anticholinergic toxicity as "red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter" 3

High-Risk Populations Requiring Monitoring

Elderly Patients (Priority Population)

Elderly patients are particularly vulnerable to anticholinergic adverse effects and should have these medications deprescribed whenever possible. 1

The 2021 Mayo Clinic polypharmacy guidelines specifically identify strongly anticholinergic medications for deprescribing in older adults, including:

• Older antihistamines (diphenhydramine)
• Muscle relaxants (cyclobenzaprine)
• Overactive bladder agents (oxybutynin)

These medications cause:

• Decline in cognition and functional status
• Increased fall risk
• Episodes of confusion or delirium
• Emergency department visits and hospitalizations
• All of which raise cardiovascular stress and mortality risk 1

Patients with Cardiovascular Disease

For patients with existing cardiovascular conditions, anticholinergics pose specific risks:

• Coronary artery disease: Tachycardia may precipitate or worsen angina 3
• Heart failure: Increased heart rate reduces diastolic filling time
• Arrhythmias: May trigger or worsen tachyarrhythmias
• Hypertension: The combination of tachycardia and potential blood pressure elevation creates additive cardiovascular stress

Monitoring Recommendations

When anticholinergics cannot be avoided, implement this monitoring protocol:

Baseline Assessment:

• Blood pressure (sitting and standing to detect orthostatic changes)
• Heart rate at rest
• ECG if patient has known cardiac disease
• Cognitive baseline assessment in elderly patients

Ongoing Monitoring:

• Blood pressure and heart rate at each visit
• Standing blood pressure measurements in elderly patients (increased fall risk from combined effects) 4
• Watch for new-onset confusion, which may indicate anticholinergic burden 1
• Monitor for urinary retention and constipation (can increase cardiovascular stress through straining)

Clinical Precautions and Management

For Patients with Hypertension

Do not use anticholinergics as first-line therapy in hypertensive patients. If unavoidable:

1. Ensure blood pressure is well-controlled before initiating anticholinergic therapy
2. Consider that elderly hypertensive patients may need gradual dose titration of antihypertensives 4
3. The 2017 ACC/AHA guidelines emphasize careful BP monitoring in elderly patients with orthostatic risk 5, 6
4. Multiple-drug antihypertensive therapy is typically required in elderly patients 4

Anticholinergic Burden Concept

The cumulative effect of multiple anticholinergic medications ("anticholinergic burden") is more dangerous than any single agent. 1

The Drug Burden Index demonstrates that drugs with strong anticholinergic properties are associated with:

• Cognitive decline
• Functional status deterioration
• Decreased activities of daily living scores
• Increased healthcare costs from complications 1

Practical Algorithm for Decision-Making

Step 1: Assess Necessity

• Is there a non-anticholinergic alternative available?
• If yes → switch to alternative
• If no → proceed to Step 2

Step 2: Risk Stratification

• Age ≥65 years + any cardiovascular disease = HIGH RISK
• Age ≥65 years OR cardiovascular disease = MODERATE RISK
• Age <65 years + no cardiovascular disease = LOWER RISK

Step 3: For HIGH RISK patients

• Avoid anticholinergics per Beers Criteria 1
• If absolutely necessary, use lowest effective dose
• Monitor BP and HR weekly for first month, then monthly
• Measure standing BP at each visit

Step 4: For MODERATE RISK patients

• Use lowest effective dose
• Monitor BP and HR at 2 weeks, 1 month, then every 3 months
• Check standing BP if any dizziness reported

Common Pitfalls to Avoid

1. Overlooking over-the-counter medications: Many OTC sleep aids and cold medications contain diphenhydramine with strong anticholinergic effects 1

2. Ignoring cumulative burden: Patients may be on multiple medications with mild anticholinergic properties that collectively cause significant effects 1

3. Attributing symptoms to aging: Confusion, falls, and cognitive decline may be dismissed as "normal aging" when they are actually medication-induced 3

4. Failing to measure standing BP: Orthostatic hypotension from anticholinergics increases fall risk, which can lead to cardiovascular events in elderly patients 4

5. Not considering thermoregulation: Anticholinergics block sweating, potentially causing life-threatening hyperthermia that stresses the cardiovascular system 3